Determination of Affinity and Activity of Ligands at the Human Neuropeptide Y Y <sub>4</sub> Receptor by Flow Cytometry and Aequorin Luminescence
Ralf Ziemek(University of Regensburg), Armin Buschauer(University of Regensburg), Chiara Cabrele(University of Regensburg), Anja Kraus(University of Regensburg), Annette G. Beck‐Sickinger(Leipzig University), Erich Schneider(AO Foundation), Günther Bernhardt(University of Regensburg)
Cited by 40
Related Papers
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Herbal drugs and phytopharmaceuticals
|Pharmaceutica Acta Helvetiae|1995|415
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
|European Journal of Pharmacology|1994|374